Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Ze Yu Shuang"'
Autor:
Hong-Wei Sun, Wen-Chao Wu, Hai-Tian Chen, Yi-Tuo Xu, Yan-Yan Yang, Jing Chen, Xing-Juan Yu, Zilian Wang, Ze-Yu Shuang, Limin Zheng
Publikováno v:
Frontiers in Immunology, Vol 11 (2021)
Solid tumors are often challenged by hypoxic and nutrient-deprived tumor microenvironments (TME) as tumors progress, due to limited perfusion and rapid nutrient consumption. While cancer cells can demonstrate the ability to survive in nutrient-depriv
Externí odkaz:
https://doaj.org/article/5ccfeef4016a454f9cfe8feaf7c1b5c7
Autor:
Limin Zheng, Zilian Wang, Ming Shi, Ze-Yu Shuang, Hai-Tian Chen, Xing-Juan Yu, Han-Yue OuYang, Jing Chen, Hong-Wei Sun, Wen-Chao Wu
Supplementary Figures 1-7 and Supplementary Tables 1 and 2.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b8d92fb630005d9dd5487b902b6bc25
https://doi.org/10.1158/2326-6066.22542654
https://doi.org/10.1158/2326-6066.22542654
Autor:
Limin Zheng, Zilian Wang, Ming Shi, Ze-Yu Shuang, Hai-Tian Chen, Xing-Juan Yu, Han-Yue OuYang, Jing Chen, Hong-Wei Sun, Wen-Chao Wu
Tumor-associated myeloid cells are one of the prominent components of solid tumors, serving as major immune regulators for the tumor microenvironment (TME) and an obstacle for immune-checkpoint blocking (ICB) therapy. However, it remains unclear how
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0bb3dbc01989721ec079c767fde0aed8
https://doi.org/10.1158/2326-6066.c.6550011
https://doi.org/10.1158/2326-6066.c.6550011
Publikováno v:
Translational Cancer Research. 6:1188-1196
Background: Tumor-draining lymph nodes (TDLN) played an important role in initiating immune responses. However, the immune status of TDLN in hepatocellular carcinoma (HCC) had not been well studied. Methods: We extracted the immune cells from the TDL
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ae4db6feb9e01eb6c4855ac2a0eddcf7
https://doi.org/10.21037/tcr.2017.11.14
https://doi.org/10.21037/tcr.2017.11.14
Autor:
Hai-Tian Chen, Wen-Chao Wu, Ze-Yu Shuang, Ming Shi, Zilian Wang, Limin Zheng, Han-Yue OuYang, Hong-Wei Sun, Jing Chen, Xing-Juan Yu
Publikováno v:
Cancer immunology research. 7(10)
Tumor-associated myeloid cells are one of the prominent components of solid tumors, serving as major immune regulators for the tumor microenvironment (TME) and an obstacle for immune-checkpoint blocking (ICB) therapy. However, it remains unclear how
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::14c4bbb3cf23cc918ca70a9bdef48d2a
https://pubmed.ncbi.nlm.nih.gov/31387898
https://pubmed.ncbi.nlm.nih.gov/31387898
Autor:
Guo Liang Huang, Xiaojun Lin, Hui Yun Wang, Shu Hong Li, Mei Yin Zhang, Ze Yu Shuang, Xiang-Ming Lao, Guo He Lin, Shengping Li, Li Xu
Publikováno v:
BMC Cancer
Background The clinical significance of microRNAs (miRNAs) in intrahepatic cholangiocarcinoma (ICC) is unclear. The objective of this study is to examine the miRNA expression profiles and identify a miRNA signature for the prognosis of ICC. Methods U
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c602b6d376edcf7c0ddceb149fcc27f6
http://europepmc.org/articles/PMC4344737
http://europepmc.org/articles/PMC4344737
Autor:
Xiang Ling Wang, Qian Yang, Bing Qi, Ze Yu Shuang, Xin Li, Hai Ying Wan, Hua Tang, Pei Pei Zhang, Wei Zhao, Shengping Li, Min Liu
MicroRNAs (miRNAs) have been shown to play important roles in carcinogenesis. However, their underlying mechanisms of action in hepatocellular carcinoma (HCC) are poorly understood. Recent evidence suggests that epigenetic silencing of miRNAs through
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::010f25a68fe06a1f6a5ed7350f438b6b
https://europepmc.org/articles/PMC4148894/
https://europepmc.org/articles/PMC4148894/
Autor:
Yong cheng Liu, Shengping Li, Xiang-Ming Lao, Jing Xu, Guohe Lin, Wen Chao Wu, Limin Zheng, Ze Yu Shuang
Publikováno v:
Cancer letters. 354(2)
Epithelial-mesenchymal transition (EMT) is a major factor that facilitates the invasiveness and metastasis of cancer. Recent studies have demonstrated that EMT plays a key role in generating cancer stem cells (CSCs). This study aimed to investigate t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::88d1be2b3527d2b59e88ac2e70ffe643
https://pubmed.ncbi.nlm.nih.gov/25194504
https://pubmed.ncbi.nlm.nih.gov/25194504
Autor:
Xiang-Ming Lao, Li Xu, Jie Tian Jin, Xin Huang, Yi Ze Mao, Guo He Lin, Xiaojun Lin, Jian Lin Chen, Bo Kang Cui, Jun Wang, Shengping Li, Ze Yu Shuang, Jing Ping Yun
Publikováno v:
Medicine
Supplemental Digital Content is available in the text
Cytokine-induced killer (CIK) cell therapy has recently been used as an adjuvant setting following resection of hepatocellular carcinoma (HCC), while its benefit remains unclear. This study a
Cytokine-induced killer (CIK) cell therapy has recently been used as an adjuvant setting following resection of hepatocellular carcinoma (HCC), while its benefit remains unclear. This study a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5b82aaddc62f5d0eaeff5361c4662ba4
https://doi.org/10.1097/md.0000000000002665
https://doi.org/10.1097/md.0000000000002665
Autor:
Yong Qiang Li, Li Xu, Wan Yee Lau, Timothy M. Pawlik, Jian Chuan Xia, Xiang-Ming Lao, Yaojun Zhang, Minshan Chen, Yuhree Kim, Ze Yu Shuang, Shengping Li, Jun Wang
Publikováno v:
OncoImmunology. 5:e1083671
There is no generally accepted adjuvant therapy for hepatocellular carcinoma (HCC) after curative resection. Autologous cytokine-induced killer (CIK) cells therapy has been reported to improve outcomes of patients with HCC, but its role as an adjuvan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1db18bd294fd1abf89ad9c387645f802
https://doi.org/10.1080/2162402x.2015.1083671
https://doi.org/10.1080/2162402x.2015.1083671